FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2295077612> ?p ?o ?g. }

• W2295077612 abstract "Sill and co-workers1 report that germline variation in semaphorin 4A (SEMA4A) influences colorectal cancer (CRC) risk. This stems from identifying the SEMA4A p.Val78Met variant in one kindred with familial colorectal cancer type X (FCCTX) and subsequently p.Gly484Ala (c.1451G>C, rs148744804) and p.Ser326Phe (c.977C>T) mutations along with the single nucleotide polymorphism (SNP) p.Pro682Ser (c.2044C>T, rs76381440) among an additional 53 FCCTX cases. In comparing the frequency of rs76381440 genotype in 47 FCCTX cases and 1,138 controls, c.2044T carrier status was reported to be associated with 6.79-fold increased CRC risk1.Here, we report a well-powered study that casts doubt on SEMA4A as a CRC predisposition gene. This has important implications for clinical genetics because inappropriate screening or intervention might be recommended to carriers.First, we studied the contribution of the recurrent variants, rs148744804 and rs76381440, to CRC analysing 6,856 CRC cases and 10,090 controls from six European populations as previously described2,3. These comprised (1) 3,666 English case patients (n=250 from the CORGI study; n=957 from the QUASAR study; n=1,168 from NSCCG; n=1,291 from a Leeds case–control series) and 6,140 control patients (n=5,694 from the 1958 Birth Cohort; n=446 from the Leeds series); (2) 2,052 Scottish CRC cases and 2,004 Scottish controls (n=1,452 from the 1935 and 1928 Lothian birth cohorts; n=552 from generation Scotland); (3) 276 Spanish cases and 284 controls; (4) 800 Dutch samples (n=337 Leiden cases and n=337 controls; n=74 Groningen cases and n=52 controls); (5) 199 Portuguese cases and 186 controls and (6) 1,339 German samples (n=77 Heidelberg cases and n=88 controls; n=175 Kiel cases and n=999 controls). Collectively these samples provide >99% power (α=0.05) to detect the lower limit of the point estimate reported by Sill and co-workers for the association between p.Pro682Ser and CRC1) (odds ratio [OR]=2.6).We used Infinium HumanExome BeadChips (Illumina San Diego, CA) to genotype our samples as previously described2,3 and extracted the genotypes for rs148744804 and rs76381440. We validated genotyping by sequencing 541 random samples, providing very strong concordance (r2=1.0 and 0.99 for rs148744804 and rs76381440, respectively; Supplementary Table 1). We used principal component analysis to confirm ancestral comparability of cases and controls (Supplementary Figure 1).None of the six series showed a statistically significant difference in frequency of rs148744804 or rs76381440 genotype between cases and controls (Table 1). In a meta-analysis of data from all studies, we found no association between c.1451C or c.2044T carrier status and CRC (OR=1.14, 95% confidence interval [CI]: 0.58–2.24, Pheterogenity=0.87, I2=0% and OR=1.04, 95% CI: 0.89–1.22, Pheterogenity=0.36, I2=9%, respectively; Fig. 1). Principal component analysis adjustment had no impact on findings.Figure 1Forest plot of association between rs148744804 and rs76381440 SEMA4A genotypes and colorectal cancer risk.Table 1SEMA4A rs76381440 (p.Pro682Ser, c.2044C>T) and rs148744804 (p.Gly484Ala, c.1451G>C) genotype counts and association statistics for the six colorectal cancer case–control studies.Following on from these analyses we examined the mutational spectra of SEMA4A in 1,006 familial early-onset CRC cases (≥1 first-degree relative with CRC, <56yrs; 158 with FCCTX) from the National Study of Colorectal Cancer Genetics (NSCCG) and 1,609 1958 BC controls sequenced using Illumina Truseq exome capture in conjunction with HiSeq2000 technology (Supplementary Figure 2, Supplementary Table 2). Over 99% of the SEMA4A transcript was covered at a depth greater than 10 reads (average coverage 38 ×, Supplementary Figure 2). We identified 28 protein changing variants in 354 samples. Of these variants, there were three unique frameshifts present in two controls and one case. Overall, 13% of CRC cases (16% FCCTX) had a protein changing variant in SEMA4A in comparison with 14% of controls.There are a number of possible explanations for the disparity between our findings and those reported by Sill and co-workers1. Population stratification can lead to spurious associations, and this is especially important with rare variants. The study by Sill and co-workers did not account for this and indeed in comparing the frequency of rs14874408 included cases from both the US and Germany, whereas we ensured ancestral comparability of case patients and control subjects from single nucleotide polymorphism genotypes, thereby excluding this as a source of bias. Generalisability is central to establishing a mutation–phenotype relationship. The evidence for p.Val78Met being causative in FCCTX is based on incomplete segregation in the family reported by Schulz et al. Hence there is the issue of type 1 error.Much of the missing heritability of CRC is likely to be a result of high/moderate penetrance mutations and rare variants. As illustrated by the recent identification of POLE and POLD1 as a cause of familial CRC4, this class of susceptibility is especially important in understanding cancer biology and for clinical practice. Hence there is a strong rationale for seeking to identify additional such genes. Given the high frequency of deleterious mutations carried by the healthy population, it is becoming increasingly clear that robust and well-powered studies are required to prevent erroneous findings from exome-sequencing projects being asserted to be causal of disease.In conclusion, in this well-powered study, we find no evidence to support variation in SEMA4A as a determinant of CRC risk. Given that a priori SEMA4A is not a strong candidate CRC predisposition gene, having previously been shown to cause eye disease, we feel that caution should be exercised before SEMA4A is considered as a cause of CRC." @default.
• W2295077612 created "2016-06-24" @default.
• W2295077612 creator A5004647151 @default.
• W2295077612 creator A5007530177 @default.
• W2295077612 creator A5008037862 @default.
• W2295077612 creator A5011631971 @default.
• W2295077612 creator A5016100282 @default.
• W2295077612 creator A5017796230 @default.
• W2295077612 creator A5020325857 @default.
• W2295077612 creator A5022550644 @default.
• W2295077612 creator A5032104062 @default.
• W2295077612 creator A5033225491 @default.
• W2295077612 creator A5040598662 @default.
• W2295077612 creator A5046053439 @default.
• W2295077612 creator A5046770257 @default.
• W2295077612 creator A5047343715 @default.
• W2295077612 creator A5064859301 @default.
• W2295077612 creator A5066379608 @default.
• W2295077612 creator A5066478601 @default.
• W2295077612 creator A5072552062 @default.
• W2295077612 creator A5079734994 @default.
• W2295077612 creator A5082417116 @default.
• W2295077612 creator A5083173073 @default.
• W2295077612 creator A5084782084 @default.
• W2295077612 creator A5089552905 @default.
• W2295077612 creator A5090212645 @default.
• W2295077612 date "2016-03-10" @default.
• W2295077612 modified "2023-10-18" @default.
• W2295077612 title "Correspondence: SEMA4A variation and risk of colorectal cancer" @default.
• W2295077612 cites W2089871121 @default.
• W2295077612 cites W2145606954 @default.
• W2295077612 cites W2158757937 @default.
• W2295077612 cites W4322700674 @default.
• W2295077612 doi "https://doi.org/10.1038/ncomms10611" @default.
• W2295077612 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4792923" @default.
• W2295077612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26961734" @default.
• W2295077612 hasPublicationYear "2016" @default.
• W2295077612 type Work @default.
• W2295077612 sameAs 2295077612 @default.
• W2295077612 citedByCount "7" @default.
• W2295077612 countsByYear W22950776122016 @default.
• W2295077612 countsByYear W22950776122017 @default.
• W2295077612 countsByYear W22950776122018 @default.
• W2295077612 countsByYear W22950776122020 @default.
• W2295077612 countsByYear W22950776122023 @default.
• W2295077612 crossrefType "journal-article" @default.
• W2295077612 hasAuthorship W2295077612A5004647151 @default.
• W2295077612 hasAuthorship W2295077612A5007530177 @default.
• W2295077612 hasAuthorship W2295077612A5008037862 @default.
• W2295077612 hasAuthorship W2295077612A5011631971 @default.
• W2295077612 hasAuthorship W2295077612A5016100282 @default.
• W2295077612 hasAuthorship W2295077612A5017796230 @default.
• W2295077612 hasAuthorship W2295077612A5020325857 @default.
• W2295077612 hasAuthorship W2295077612A5022550644 @default.
• W2295077612 hasAuthorship W2295077612A5032104062 @default.
• W2295077612 hasAuthorship W2295077612A5033225491 @default.
• W2295077612 hasAuthorship W2295077612A5040598662 @default.
• W2295077612 hasAuthorship W2295077612A5046053439 @default.
• W2295077612 hasAuthorship W2295077612A5046770257 @default.
• W2295077612 hasAuthorship W2295077612A5047343715 @default.
• W2295077612 hasAuthorship W2295077612A5064859301 @default.
• W2295077612 hasAuthorship W2295077612A5066379608 @default.
• W2295077612 hasAuthorship W2295077612A5066478601 @default.
• W2295077612 hasAuthorship W2295077612A5072552062 @default.
• W2295077612 hasAuthorship W2295077612A5079734994 @default.
• W2295077612 hasAuthorship W2295077612A5082417116 @default.
• W2295077612 hasAuthorship W2295077612A5083173073 @default.
• W2295077612 hasAuthorship W2295077612A5084782084 @default.
• W2295077612 hasAuthorship W2295077612A5089552905 @default.
• W2295077612 hasAuthorship W2295077612A5090212645 @default.
• W2295077612 hasBestOaLocation W22950776121 @default.
• W2295077612 hasConcept C121332964 @default.
• W2295077612 hasConcept C121608353 @default.
• W2295077612 hasConcept C126322002 @default.
• W2295077612 hasConcept C2778334786 @default.
• W2295077612 hasConcept C44870925 @default.
• W2295077612 hasConcept C526805850 @default.
• W2295077612 hasConcept C71924100 @default.
• W2295077612 hasConceptScore W2295077612C121332964 @default.
• W2295077612 hasConceptScore W2295077612C121608353 @default.
• W2295077612 hasConceptScore W2295077612C126322002 @default.
• W2295077612 hasConceptScore W2295077612C2778334786 @default.
• W2295077612 hasConceptScore W2295077612C44870925 @default.
• W2295077612 hasConceptScore W2295077612C526805850 @default.
• W2295077612 hasConceptScore W2295077612C71924100 @default.
• W2295077612 hasIssue "1" @default.
• W2295077612 hasLocation W22950776121 @default.
• W2295077612 hasLocation W229507761210 @default.
• W2295077612 hasLocation W22950776122 @default.
• W2295077612 hasLocation W22950776123 @default.
• W2295077612 hasLocation W22950776124 @default.
• W2295077612 hasLocation W22950776125 @default.
• W2295077612 hasLocation W22950776126 @default.
• W2295077612 hasLocation W22950776127 @default.
• W2295077612 hasLocation W22950776128 @default.
• W2295077612 hasLocation W22950776129 @default.
• W2295077612 hasOpenAccess W2295077612 @default.
• W2295077612 hasPrimaryLocation W22950776121 @default.
• W2295077612 hasRelatedWork W2075214100 @default.
• W2295077612 hasRelatedWork W2364051953 @default.

• next